Novaliq Conducts a First-in-Class Ocular Neuropathic Pain and Anti-Inflammatory Cannabinoid Drug Development Program in Collaboration with the University of Cologne, Germany
HEIDELBERG, Germany--(BUSINESS WIRE)--#DED--Novaliq announced successful application of first-in-class ocular neuropathic pain & anti-inflammatory cannabinoid-based dry eye disease treatment approach in collaboration with University of Cologne.